Egenesis stock

Egenesis Stock

HealthTech
Founded: 2015Funding to Date: $429Mhttps://www.egenesisbio.com

Egenesis is developing a gene editing and genome engineering platform aimed at revolutionizing solid organ and therapeutic cell transplantation for treating life-threatening illnesses. The company's platform provides gene editing techniques to create human-compatible organ tissue cells and spearheads programs in kidney and islet cell transplantation, allowing patients to recover and maintain a healthy life.

Investors Include:

Alta Partners, SymBiosis Capital Management, Samsara BioCapital, Fan Ventures, Polaris Partners, HBM Partners, DaVita, Farallon Capital Management, T1D Fund, Osage University Partners, Eisai Innovation, Irving Investors, HBM Healthcare Investments, Codon Capital, Alexandria Venture Investments, The Invus Group, Altium Capital, E Squared Capital Management, Parkwood, Khosla Ventures, LifeSci Venture Partners, Catalio Capital Management, Lux Capital, Wellington Partners, Altium Capital Management.

Own Egenesis stock or options?

Get an instant valuation

  • Completely free
  • 100% confidential & secure
  • Takes less than a minute
100% private & secure

Management Team

Michael Curtis Ph.DCo-Founder, Chief Executive Officer & President
Lauren TahmoushController
Jennifer BergheiserChief Business Officer
Luis QueirozStrategic Advisor
William Westlin Ph.DExecutive Vice President, Research & Development
George Church Ph.DCo-Founder & Advisor
Elizabeth RobertsChief People Officer
Luhan Yang Ph.DCo-Founder, President, Co-Chief Scientific Officer & Board Member

Board Members

Rahul Kakkar MDBoard Member
Albert WiegmanBoard Member
Isaac Ciechanover MDBoard Member
Steven Gillis Ph.DBoard Member
Lucio Iannone Ph.DBoard Member
Rainer Strohmenger MDBoard Member

Egenesis’s stock FAQs

Other HealthTech Companies in Collective's mid-stage Target Portfolio.

A2 Bio stock
Aardvark Therapeutics stock
AcuityMD stock
Alamar Biosciences stock
Alterome Therapeutics stock
Arbor Biotechnologies stock
Attralus stock
Be Biopharma stock
Bluejay Therapeutics stock
Brightside Health stock
Capstan Therapeutics stock
Carrum Health stock
Casana stock
Cellanome stock
Centivo stock
Chroma Medicine stock
Conformal stock
Convergent Therapeutics stock
Covera Health stock
Detect stock
Dewpoint Therapeutics stock
Dispatch Biotherapeutics stock
Elektrofi stock
Engrail Therapeutics stock
Equip stock
Firefly Health stock
Flare Therapeutics stock
Florence stock
FogPharma stock
Foresight Mental Health stock
Frontier Medicines stock
Genesis Therapeutics stock
Graviton BioScience stock
Hexagon Bio stock
Iambic Therapeutics stock
IDRx stock
Inceptive stock
Infinitus Systems stock
KSQ stock
Levels stock
LifeMine stock
LightForce stock
Loyal stock
Luna Physical Therapy stock
Lycia Therapeutics stock
Marea stock
Medallion stock
Nalu Medical stock
Neuron23 stock
NextPoint stock
OrsoBio stock
Ossium Health stock
Ostro stock
Overjet stock
Pager stock
Paradigm stock
Paradromics stock
Pathalys Pharma stock
Pelago stock
Pomelo Care stock
Rad AI stock
ReCode Therapeutics stock
Regard stock
Rivus Pharmaceuticals stock
Route 92 stock
SalioGen Therapeutics stock
Santa Ana Bio stock
Seismic Therapeutic stock
Sionna stock
SmarterDx stock
SmithRx stock
Strand Therapeutics stock
Suki stock
Syllable stock
Synchron stock
Synthekine stock
Third Arc Bio stock
Tome Biosciences stock
Tomorrow Health stock
Triveni Bio stock
Two Chairs stock
Unlearn stock
Vanqua Bio stock
Verse Medical stock
Viome Life Sciences stock
Vizgen stock

Companies backed by the same VC's

Cape Analytics stock
Cobot stock
Cyberhaven stock
Fortera stock
Fulfil Solutions stock
Future stock
Glydways stock
Homebase stock
Jetty stock
Loyal stock
Lula stock
Novi Connect stock
Polly stock
Rad AI stock
Replit stock
Rightway stock
SingleStore stock
Skyflow stock
Speak stock
SWORD Health stock
Syllable stock
Synchron stock
ThoughtSpot stock
Truework stock
Vectra stock
Verdagy stock
Viome Life Sciences stock